Around 40% of patients stopped taking their GLP-1 drug within the first year, rising to nearly 60% by the end of two years
MDWatch also offers the Medicare GLP-1 Bridge Program FDA-approved GLP-1s for as little as a $50 copay, if you qualify
Shkorfu, W., Fadel, A., Hamsho, M., Ranneh, Y., & Shahbaz, H
Patients who choose surgery or GLP-1 RA medications to treat obesity should also commit to lifestyle modifications for the best chance of success
Some BCBS insurance plans have reduced or eliminated weight loss drug coverage due to rising costs, although it may still be covered for other indications, such as cardiovascular risk reduction and liver disease (MASH)
This highlights the variability in patient response in less controlled real-world environments